Epidemiological Surveillance of SARSCov2 in ß-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges.

Torti, Lorenza; Sorrentino, Francesco; Maffei, Laura; De Fabritiis, Paolo; Abruzzese, Elisabetta

Torti, Lorenza; Sorrentino, Francesco; Maffei, Laura; De Fabritiis, Paolo; Abruzzese, Elisabetta.

Afiliación

Torti L; Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome Italy.
Sorrentino F; Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome Italy.
Maffei L; Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome Italy.
De Fabritiis P; Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome Italy.
Abruzzese E; Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2), Rome Italy.

Mediterr J Hematol Infect Dis ; 15(1): e2023007, 2023.

Article en En | MEDLINE | ID: mdl-36660359

Palabras clave

Immunity; Monoclonal antibodies; Reinfection; SARSCov2; Thalassemia; Vaccination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Screening_studies Idioma: En Revista: Mediterr J Hematol Infect Dis Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google